FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

27995511000001106: Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Nov 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
87585901000001115 Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100796701000001119 Ursodeoxycholic acid 150mg tablets (Teva UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) Is a Product containing precisely ursodeoxycholic acid 150 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) Has active ingredient Ursodeoxycholic acid false Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) Has specific active ingredient Ursodeoxycholic acid true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) 60 tablet 6 x 10 tablets Has AMP True Ursodeoxycholic acid 150mg tablets (Auden McKenzie (Pharma Division) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start